iTech Medical receives CE Mark approval for Muscle Pattern Recognition System

iTech Medical, Inc. (OTCBB:IMSU) (Frankfurt:0IM), a medical information technology company, announced today that it has received CE Mark approval for the commercial sale of the Company's Muscle Pattern Recognition (MPR) System in Europe. This approval allows for the marketing and sale of the device in the European Union (EU) and all countries recognizing the CE Mark. The MPR System is a non-invasive clinical assessment tool being developed to assist in the diagnosis and treatment of back and neck pain, one of the most common chronic conditions in the industrialized world. On December 13, 2010, the Company reported that it had received Health Canada approval to begin sales and marketing of the MPR System in Canada.

"The achievement of the CE Mark for our MPR System represents another critical milestone in the history of iTech Medical," said Wayne Cockburn, President & CEO at iTech Medical. 

It is estimated that 80% of the European population will suffer back pain at some time in their lives and in excess of one third of the European workforce suffer from low back pain. Although many cases resolve within 2-4 weeks, many patients will have recurring pain within 1 year following the first episode of back pain.

"Back and neck pain cases are one of the greatest health problems in the European Union, with direct and indirect treatment costs in excess of 100 billion Euros a year," said Mr. Cockburn. "Our device has the potential to benefit a large number of patients that suffer from neck and back pain while at the same time reducing the costs related to diagnosing and treating this condition. We are extremely pleased with this approval and we look forward to introducing the MPR System in the European Community in 2011."

The Company stated that it is currently evaluating its marketing and distribution strategy options, including strategic partners.